Comment: Nexium plaintiffs' lawsuit an 'assault on capitalism,' juror says

The closely watched Nexium pay-for-delay case, a recent win for AstraZeneca over drug purchasers, turned in part on jurors who felt that suing a drug innovator was an "assault on capitalism." The comments...

Already a subscriber? Click here to view full article